Cna Financial Corp Dexcom Inc Transaction History

Cna Financial Corp

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 10, 2023	SELL	$84.98 - $122.67 $392,267 - $566,244	-4,616 Reduced 43.24%	6,059 $686,000
Q3 2022 Nov 10, 2022	SELL	$76.35 - $94.18 $46,802 - $57,732	-613 Reduced 5.43%	10,675 $860,000
Q2 2022 Aug 09, 2022	BUY	$67.99 - $132.89 $575,603 - $1.13 Million	8,466 Added 300.0%	11,288 $841,000
Q4 2021 Feb 11, 2022	SELL	$129.87 - $162.82 $25,454 - $31,912	-196 Reduced 6.49%	2,822 $1.52 Million
Q3 2020 Nov 12, 2020	SELL	$95.51 - $112.95 $23,113 - $27,333	-242 Reduced 7.42%	3,018 $1.24 Million
Q2 2020 Aug 13, 2020	BUY	$62.68 - $105.34 $51,585 - $86,694	823 Added 33.77%	3,260 $1.32 Million
Q1 2020 May 12, 2020	BUY	$47.79 - $75.63 $116,464 - $184,310	2,437 New	2,437 $656,000

1,014

351M

5.51M

5.6M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $31B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Cna Financial Corp, based on Form 13F filings with the SEC.

Stay updated on Cna Financial Corp with notifications on news.